ResearcherCity of HopeActive in the last 2 years
Paul Wong
Matched on ORCID iD 0000-0002-5833-0331; OpenAlex author ID A5070651494. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 3
- Robotic pancreatectomy for pancreatic adenocarcinoma: evolving trends in patient selection and practice patterns across a decade. Co-author DOI 10.1016/j.hpb.2025.06.009↗
- Distinct Indications for Adjuvant Therapy in Resected Invasive Mucinous Cystic Neoplasms of the Pancreas Compared with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-024-15841-5↗
- Inhibition of de novo pyrimidine synthesis augments Gemcitabine induced growth inhibition in an immunocompetent model of pancreatic cancer. Co-author DOI 10.7150/ijbs.60473↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ajay V. Maker · 2 shared papers, 2024–2025 · strength 0.51
- Paper Robotic pancreatectomy for pancreatic adenocarcinoma: evolving trends in patient selection and practice patterns across… DOI 10.1016/j.hpb.2025.06.009↗
- Paper Distinct Indications for Adjuvant Therapy in Resected Invasive Mucinous Cystic Neoplasms of the Pancreas Compared with … DOI 10.1245/s10434-024-15841-5↗
- Laleh Golkar Melstrom · 2 shared papers, 2021–2025 · strength 0.42
- Paper Robotic pancreatectomy for pancreatic adenocarcinoma: evolving trends in patient selection and practice patterns across… DOI 10.1016/j.hpb.2025.06.009↗
- Paper Inhibition of de novo pyrimidine synthesis augments Gemcitabine induced growth inhibition in an immunocompetent model o… DOI 10.7150/ijbs.60473↗
- Yuman Fong · 1 shared paper, 2025 · strength 0.30
- Mohamed A. Adam · 1 shared paper, 2024 · strength 0.21
- Adnan A. Alseidi · 1 shared paper, 2024 · strength 0.21
- Eric K. Nakakura · 1 shared paper, 2024 · strength 0.21
- Kimberly Saunders Kirkwood · 1 shared paper, 2024 · strength 0.21
- Thuy Xuan Phan · 1 shared paper, 2021 · strength 0.12
- Marcela d'Alincourt Salazar · 1 shared paper, 2021 · strength 0.12
- Lifeng Yang · 1 shared paper, 2021 · strength 0.12
- Don J. Diamond · 1 shared paper, 2021 · strength 0.12
- Joshua D. Rabinowitz · 1 shared paper, 2021 · strength 0.12
- Ziv Gil · 1 shared paper, 2021 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.